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Table 1
mtDNA Control Region Variation in Iberian Patients and
Controls
Sample
ID Origin Control Region Variationa
1 Portuguese patient 126, 187, 189, 215T, 223,
264, 270, 278, 311
2 Portuguese patient 126, 187, 189, 223, 264,
270, 278, 293, 311
3 Spanish patient 126, 187, 189, 223, 264,
270, 278, 293, 311, 360
4 Spanish patient 126, 187, 189, 223, 264,
270, 278, 293, 311
5 Portuguese control 104, 187, 189, 223, 270,
278, 289, 293, 311
6 Portuguese control 126, 187, 189, 223, 264,
270, 278, 293, 311
7 Portuguese control 126, 187, 189, 223, 264,
270, 278, 293, 311
8 Portuguese control 126, 187, 189, 223, 264,
270, 278, 293, 311
a Nucleotide positions (16000) between nt 16090 and
16375, different from the Cambridge Reference Sequence
(Anderson et al. 1981). Mutations are transitions (T↔C,
A↔G), unless the base change is specified explicitly.
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About the “Pathological” Role of the mtDNA T3308C
Mutation)
To the Editor:
Numerous mtDNAmutations have been associated with
the mitochondrial myopathy, encephalopathy, lactic ac-
idosis, and strokelike episodes (MELAS) syndrome
(MIM 540000). These include transitions at nucleotide
positions (nt) 1642, 3243, 3252, 3256, 3271, 3291,
3308, and 9957, and a 4-bp deletion beginning at nt
14787. For some of these mutations (A3243G, C3256T,
and T3271C), the causal relationship with the pheno-
type has been confirmed, whereas for others, the status
is still provisional (MITOMAP). The T3308C mutation
in the NADH dehydrogenase subunit 1 (ND1) is a mem-
ber of the “provisional” group and was described in a
Spanish subject affected by MELAS and bilateral striatal
necrosis. This mutation changes the highly conserved
methionine 1 to a threonine, was heteroplasmic in both
the proband and her asymptomatic mother, and was
absent in 130 normal and other-disease controls (Cam-
pos et al. 1997). More recently, a homoplasmic T3308C
mutation has also been reported in a colorectal tumor,
in which it was associated with two other somatic ho-
moplasmic transitions, T710C and T1738C. It has been
suggested that these mutations could have a functional
effect in mitochondrial selection (Polyak et al. 1998).
However, doubts about the pathological significance of
the T3308C mutation have been raised by a study in-
volving 37 Portuguese patients with a clinical phenotype
of mitochondrial encephalomyopathies and 150 Portu-
guese control subjects. The T3308C mutation was ob-
served in two patients and in four controls (Vilarinho
et al. 1999). In all cases it was homoplasmic.
To better define the role of this putative pathological
mutation, we did a detailed analysis of themtDNAback-
ground on which the T3308C had been reported. By
sequence analysis of several tRNA genes and their sur-
rounding sequences, we determined that, in addition
to the T3308C mutation, the mtDNA of both Portu-
guese patients harbored the combination of mutations
T1738C, T5655C, G7521A, A10398C, and A14769G
and a dinucleotide deletion at nt 514–515. We observed
the same mutations in the two Spanish patients (in the
meantime a second Spanish patient had been found) and
in the four Portuguese controls who tested positive for
the mutation. Thus, these results indicated that all these
mtDNAs were members of the same mtDNA haplo-
group and that most likely they shared the T3308C mu-
tation by descent. Intriguingly, this haplogroup harbored
the combination of mutations T3308C and T1738C,
similar to the case reported by Polyak et al. (1998). The
search in our samples for the third somatic mutation
(T710C) found in the colorectal tumor was negative.
To identify the mtDNA haplogroup harboring themu-
tation T3308C, sequence analysis of the mtDNA control
region between nt 16090 and 16375 was performed
in the eight T3308C samples (table 1). This analysis
revealed a consensus motif (16126–16187–16189–
16223–16264–16270–16278–16293–16311) that is
typical of the West African haplogroup L1b (Watson et
al. 1997; Rando et al. 1998), thus allowing us to classify
Portuguese and Spanish mtDNAs with the T3308C mu-
tation within this haplogroup. It has been determined
elsewhere, by high-resolution restriction analysis (Tor-
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roni et al. 1996, 1997), that haplogroup L1b is defined
by the RFLP motif: 185 TaqI, 2349 MboI, 2758
RsaI,3592 HpaI,3693 MboI,7055 AluI,10394
DdeI, 10806 HinfI (Chen et al. 1995; Rando et al.
1998; A. Torroni, unpublished data). Therefore, we se-
lected, among our African population samples, all those
(a total of 48) who either by RFLP analysis or by control
region sequencing had been classified asmembers of hap-
logroup L1b. Analysis of their status at nt 3308 revealed
that all of them harbored the mutation. In contrast, con-
trol samples belonging to African haplogroups L1a, L1c,
and L2 were found to lack the mutation. These results
indicate that the T3308C mutation defines exclusively
by descent haplogroup L1b mtDNAs, and it is very an-
cient since L1b probably originated in western Africa
∼12,000–19,000 years ago (Watson et al. 1997; Rando
et al. 1998). Thus, Spanish and Portuguese mtDNAs
with the T3308C mutation are of African origin, and
their presence probably reflects the arrival of North Af-
ricans during the Mesolithic Age (8000 B.C.) and/or dur-
ing the Arabic rule that started at ∼800 A.D. (Arnaiz-
Villena et al. 1997). If we take into account that hap-
logroup L1b frequencies in populations of western Af-
rica are in the range of 10%–20% (Watson et al. 1997;
Rando et al. 1998), the observed frequency in the Por-
tuguese population (∼2%–3%) indicates a significant in-
fluence of North Africans in the Iberian gene pool.
In conclusion, the T3308C mutation is an ancient
marker of a common West African haplogroup, and all
Iberian subjects with this mutation who were affected
by mitochondrial encephalomyopathies harbored hap-
logroup L1b mtDNAs. This finding is difficult to rec-
oncile with a role of this mutation in disease expression
and further indicates that haplogroup classification of
patients’ mtDNAs, followed by a search for the putative
disease mutation in phylogenetically closely related con-
trol mtDNAs, is a crucial step in the identification of
mtDNA disease mutations. Furthermore, the observa-
tion that the elimination of the methionine codon AUA
at position 1 of the ND1 subunit is common in some
human populations suggests that the maintenance of
that codon is not so critical in our species. Possibly this
is because the third codon (AUG) of the human ND1
subunit also encodes for a methionine, and the ND1
subunit of L1b mtDNAs, although it might be shortened
by two amino acids, apparently still retains its func-
tionality. However, it is intriguing that the same com-
bination, T3308C–T1738C, that characterizes haplo-
group L1b has also occurred in a colorectal tumor as
new somatic mutations. This is especially noteworthy
when it is taken into account that T1738C occurs in the
16S rRNA, a gene involved in the translation process,
and that the T3308C mutation might indeed affect the
translation process of ND1 on non-L1b mtDNA back-
grounds. This observation raises again the possibility of
polygenic models in which certain mtDNA mutations
can be functional and maintained in the population only
if they occur in combination with other specific mtDNA
mutations.
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Diaphragmatic Spinal Muscular Atrophy
with Respiratory Distress Is Heterogeneous, and One
Form Is Linked to Chromosome 11q13-q21
To the Editor:
Diaphragmatic spinal muscular atrophy (SMA) has been
delineated as a variant of infantile SMA (SMA1 [MIM
253300]) (Mellins et al. 1974; Bertini et al. 1989). The
most prominent symptoms are severe respiratory distress
resulting from diaphragmatic paralysis with eventration
shown on chest x-ray and predominant involvement of
the upper limbs and distal muscles. In contrast to classic
SMA1, in diaphragmatic SMA the upper spinal cord is
more severely affected than the lower section. The pmn
mouse presents with progressive motor neuronopathy
and a disease that closely resembles diaphragmatic SMA
(Schmalbruch et al. 1991). The pmn locus has been
mapped to murine chromosome 13 (Brunialti et al.
1995).
Here we report on nine patients from three families
with diaphragmatic SMA following autosomal recessive
inheritance. The diagnosis of diaphragmatic SMA was
made on the basis of clinical criteria (Rudnik-Scho¨ne-
born et al. 1996). Family 1 is of Lebanese origin; family
2, German origin; and family 3, Italian origin. We ob-
tained DNA samples from these families after receiving
informed consent, in accordance with the Declaration
of Helsinki.
In family 1 (fig. 1A), the parents are first cousins. The
first affected son died, at the age of 10 wk, of suspected
sudden infant death syndrome (SIDS). One daughter pre-
sented, at the age of 6 wk, with feeding difficulties and
progressive respiratory distress. Chest x-ray showed ev-
entration of the diaphragm. Mechanical ventilation was
initiated at the age of 8 wk. She developed progressive
muscular atrophy with complete paralysis of the upper
and lower limbs and mild contractures of the knee and
ankle joints. Three other children, nonidentical twin
daughters and the youngest daughter, died of respiratory
failure—the twins at the age of 8 and 9 wk and the
youngest daughter at the age of 8 wk. Autopsy specimens
were taken from gastrocnemius muscle in both twins
and from the upper spinal cord in one twin. Skeletal-
muscle histology revealed neurogenic atrophy without
signs of reinnervation. Ultrastructurally, the motor end
plates lacked nerve terminals and showed postsynaptic
degenerative changes characterized by deep invagina-
tions. The diameter of anterior spinal roots was reduced
in the upper spinal cord. The remaining motor neurons
showed chromatolysis. These findings offer two different
pathophysiological concepts: (1) degeneration of the an-
terior horn cells of the spinal cord with neurogenic mus-
cular atrophy suggests dying-forward atrophy, and (2)
presynaptic and postsynaptic signs of motor end-plate
degeneration suggest dying-back atrophy. In family 2
(fig. 1B), the first child had severe muscular hypotonia
and died, at the age of 9 wk, of cardiorespiratory failure.
The third child has been mechanically ventilated since
the age of 3 mo. In family 3 (fig. 1C), which has been
reported in detail elsewhere (Novelli et al. 1995), the
gene locus for SMA1, on chromosome 5q, has been ex-
cluded. Both affected sibs presented with respiratory in-
sufficiency right after birth and with the typical signs of
diaphragmatic SMA.
First, we confirmed that, in families 1 and 2, there is
no linkage of the trait to markers of the SMA locus on
5q11.2-q13.3, as there is in family 3. Second, the or-
thologous regions corresponding to the murine pmn
gene region on human chromosomes 1q and 7p were
excluded as gene loci responsible for the disease (Groh-
mann et al. 1998).
To locate the gene locus for diaphragmatic SMA, a
whole-genome scan was undertaken in family 1. Micro-
satellite analysis was performed, by standard semiau-
